Bedrijfsoverzicht
Nature's Sunshine Products, Inc. is a natural health and wellness enterprise that manufactures and distributes nutritional supplements and personal care products across global markets including Asia, Europe, North America, Latin America, and international regions. The company operates within the Consumer Defensive sector, specifically categorized under the Packaged Foods industry, which typically implies a business model focused on essential goods with relatively stable demand cycles. As of the latest available data, the entity holds a market capitalization of $471.48M and generates annual revenue totaling $480.14M while employing a workforce of 806 individuals. These valuation and revenue figures indicate that the company occupies a mid-cap position in its sector, suggesting it has established a significant operational footprint but remains subject to market fluctuations common among companies of this size rather than commanding the dominance of a large-cap giant.
Financiële gezondheid
The company reported a trailing twelve-month revenue of $480.14M with a corresponding net income of $19.52M and an EBITDA of $38.59M. The substantial gap between the total revenue of $480.14M and the net income of $19.52M reveals a distinct cost structure where operating expenses, cost of goods sold, and other deductions consume approximately 96% of top-line sales before arriving at the bottom line. Free cash flow stands at $32.98M, a figure that demonstrates the company's ability to generate cash after capital expenditures, thereby providing financial flexibility for debt repayment, share repurchases, or organic growth initiatives without relying on external financing. The margin profile is defined by a gross margin of 72.4%, an operating margin of 4.3%, and a profit margin of 4.1%, indicating that while the cost of goods sold is low due to high gross margins, significant operating costs erode profitability to the final profit margin level. On the balance sheet, the company holds $93.89M in cash against total debt of $18.90M, resulting in a debt-to-equity ratio of 11.70, which suggests a conservative liquidity stance given the substantial cash buffer relative to obligations. Short-term liquidity is robust, evidenced by a current ratio of 2.28, meaning the company possesses more than double the current assets necessary to cover its current liabilities. Return on equity is calculated at 12.7% while return on assets sits at 6.2%, metrics that collectively reveal the efficiency of management in deploying shareholder capital and utilizing total assets to generate profit, respectively.
Waarderingsbeoordeling
The trailing twelve-month P/E ratio is 25.41, while the forward P/E is projected at 21.81, implying that the market expects earnings growth in the future that would justify a lower multiple compared to historical performance. The price-to-book ratio stands at 2.92, indicating that the market values the company at nearly three times its net asset book value, which may reflect intangible assets or growth expectations not fully captured on the balance sheet. Alternative valuation metrics such as a price-to-sales ratio of 0.98 and an EV/EBITDA of 10.28 provide context by showing the company trades at roughly one dollar of revenue for every dollar of sales and offers earnings power relative to enterprise value that is moderate for the consumer defensive sector. The stock has traded within a 52-week range bounded by a low of $11.15 and a high of $28.14, placing the current trading price significantly below the annual peak and suggesting recent volatility or a correction from the high end of its historical trading band. The beta of 0.92 indicates that the stock's price volatility moves in tandem with the broader market, exhibiting slightly less sensitivity than the overall market index over the measurement period.
Growth & Income
Revenue growth for the trailing twelve months is recorded at 4.7%, while earnings growth is listed as N/A, preventing a direct year-over-year comparison of profitability expansion against top-line expansion within the provided dataset. Since the company does not pay a dividend, as indicated by a dividend yield of N/A and a payout ratio of 0.0%, the firm retains all of its net income for reinvestment into business operations, product development, or strategic acquisitions rather than distributing cash to shareholders. This retention strategy aligns with the profile of a non-dividend payer that prioritizes internal capital generation to fund future expansion rather than providing immediate income to investors. The overall growth and income profile is characterized by steady single-digit revenue expansion and a complete focus on capital retention, with no current mechanism for generating income through dividends for shareholders of Nature's Sunshine Products, Inc.